RT @Aiims1742: You have seen this data few times in the past months - finally out in @NEJM Efficacy of Larotrectinib in TRK Fusion–Positiv…
An impressive list of cancers with TRK fusion responding to a TRK inhibitor. Co-leader of the study is @DavidHongMD from @MDAndersonNews https://t.co/kAbwdKsscw https://t.co/9Y2LSHld8v
RT @Aiims1742: You have seen this data few times in the past months - finally out in @NEJM Efficacy of Larotrectinib in TRK Fusion–Positiv…
RT @Aiims1742: You have seen this data few times in the past months - finally out in @NEJM Efficacy of Larotrectinib in TRK Fusion–Positiv…
You have seen this data few times in the past months - finally out in @NEJM Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children Congratulations to @DavidHongMD @weldeiry @DrSarcoma @MLadanyi @sloan_kettering @MDAndersonNews h
RT @sloan_kettering: Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children | NEJM https://t.co/4n9XdrWZGt
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children | NEJM https://t.co/4n9XdrWZGt